These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27776334)

  • 1. Improved controlled release of protein from expanded-pore mesoporous silica nanoparticles modified with co-functionalized poly(n-isopropylacrylamide) and poly(ethylene glycol) (PNIPAM-PEG).
    Yu E; Lo A; Jiang L; Petkus B; Ileri Ercan N; Stroeve P
    Colloids Surf B Biointerfaces; 2017 Jan; 149():297-300. PubMed ID: 27776334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
    Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile strategy for synthesis of silica/polymer hybrid hollow nanoparticles with channels.
    Wu C; Wang X; Zhao L; Gao Y; Ma R; An Y; Shi L
    Langmuir; 2010 Dec; 26(23):18503-7. PubMed ID: 21062000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature and H
    Guo F; Li G; Zhou H; Ma S; Guo L; Liu X
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110643. PubMed ID: 31744758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed shell mesoporous silica nanoparticles for controlled drug encapsulation and delivery.
    Wu Q; Hou Y; Han G; Liu X; Tang X; Li H; Song X; Zhang G
    Nanomedicine (Lond); 2017 Nov; 12(22):2699-2711. PubMed ID: 28967827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
    Lin YS; Haynes CL
    J Am Chem Soc; 2010 Apr; 132(13):4834-42. PubMed ID: 20230032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro testing of thermoresponsive polymer-grafted core-shell magnetic mesoporous silica nanoparticles for efficient controlled and targeted drug delivery.
    Peralta ME; Jadhav SA; Magnacca G; Scalarone D; Mártire DO; Parolo ME; Carlos L
    J Colloid Interface Sci; 2019 May; 544():198-205. PubMed ID: 30844568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
    Wu L; Wu M; Zeng Y; Zhang D; Zheng A; Liu X; Liu J
    Nanotechnology; 2015 Jan; 26(2):025102. PubMed ID: 25517859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
    Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
    Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(N-isopropylacrylamide)-gated Fe3O4/SiO2 core shell nanoparticles with expanded mesoporous structures for the temperature triggered release of lysozyme.
    Yu E; Galiana I; Martínez-Máñez R; Stroeve P; Marcos MD; Aznar E; Sancenón F; Murguía JR; Amorós P
    Colloids Surf B Biointerfaces; 2015 Nov; 135():652-660. PubMed ID: 26335056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct surface grafting of mesoporous silica nanoparticles with phospholipid choline-containing copolymers through chain transfer free radical polymerization and their controlled drug delivery.
    Huang L; Wu J; Liu M; Mao L; Huang H; Wan Q; Dai Y; Wen Y; Zhang X; Wei Y
    J Colloid Interface Sci; 2017 Dec; 508():396-404. PubMed ID: 28843929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid, protein and poly(NIPAM) coated mesoporous silica nanoparticles for biomedical applications.
    Yang Y; Li J
    Adv Colloid Interface Sci; 2014 May; 207():155-63. PubMed ID: 24268194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside.
    Peng H; Dong R; Wang S; Zhang Z; Luo M; Bai C; Zhao Q; Li J; Chen L; Xiong H
    Int J Pharm; 2013 Mar; 446(1-2):153-9. PubMed ID: 23395877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refined control of thermoresponsive swelling/deswelling and drug release properties of poly(N-isopropylacrylamide) hydrogels using hydrophilic polymer crosslinkers.
    Kim S; Lee K; Cha C
    J Biomater Sci Polym Ed; 2016 Dec; 27(17):1698-1711. PubMed ID: 27573586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
    Zhang K; Zhou D; Wang Z; Zhang Y; He P
    Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
    Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
    Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of metformin from chitosan-based nanocomposite films containing mesoporous MCM-41 nanoparticles as novel drug delivery systems.
    Shariatinia Z; Zahraee Z
    J Colloid Interface Sci; 2017 Sep; 501():60-76. PubMed ID: 28433886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.